+ Site Statistics
References:
52,572,879
Abstracts:
28,705,754
PMIDs:
27,750,366
DOIs:
25,464,004
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Compounding of slow-release niacinamide capsules: feasibility and characterization



Compounding of slow-release niacinamide capsules: feasibility and characterization



International Journal of Pharmaceutical Compounding 16(5): 434-437



The purpose of this study was to assess the feasibility of extemporaneous compounding of slow-release oral dosage form of niacinamide and to evaluate its release kinetics. The model formulation (preparation) was developed in the form of powder-filled hard gelatin capsules. Two slow-release preparations with different ratios of hypromellose have been prepared and evaluated in comparison with an immediate-release preparation. The dissolution tests were performed as per United States Pharmacopoeia requirements: Type I Apparatus, over 7 hours. Both slow-release preparations, containing 40% and 60% v/v hypromellose, respectively, have showed slow release kinetics. The dissolution profiles were significantly different, with similarity factor f2<50. The dissolution data demonstrated Korsmeyer-Peppas kinetics with n values indicating anomalous transport. In conclusion, the results of this study suggest that slow-release niacinamide capsules can be successfully compounded using hypromellose as a sole release rate modifier, and that the release mechanism is comparable to hydrophilic polymer matrix-based systems.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 052269365

Download citation: RISBibTeXText

PMID: 23072204


Related references

Compounding slow-release capsules: a comprehensive review and an Excel spreadsheet for faster calculations of excipients. International Journal of Pharmaceutical Compounding 17(1): 10-22, 2013

Guidelines for Compounding Safe and Uniform Sustained Release Capsules. Journal of Pharmaceutical Care in Pain & Symptom Control 6(2): 57-65, 1998

Pharmacokinetics of theophylline. Repeated single evening administration of Pulmo-Timelets slow-release capsules in comparison with theophylline slow-release tablets. Fortschritte der Medizin 107(32): 692-696, 1989

Basics of compounding: considerations for implementing United States pharmacopeia chapter 797 pharmaceutical compounding-sterile preparations, part 18: verification of automated compounding devices for parenteral nutrition compounding and finished preparation release checks and tests. International Journal of Pharmaceutical Compounding 14(2): 142-149, 2010

Pharmaceutical development of enteric-release hard gelatin capsules in the compounding setting. International Journal of Pharmaceutical Compounding 12(2): 163-169, 2008

Release of morphine sulfate from compounded slow-release capsules: the effect of formulation on release. International Journal of Pharmaceutical Compounding 5(5): 401-405, 2001

The basics of compounding: compounding powder-filled capsules. International Journal of Pharmaceutical Compounding 3(3): 209-215, 1999

The basics of compounding: compounding special capsules. International Journal of Pharmaceutical Compounding 3(4): 291-294, 1999

Kinetic Analysis of Drug Release from Compounded Slow-release Capsules of Liothyronine Sodium (T3). International Journal of Pharmaceutical Compounding 21(5): 418-425, 2017

Quality-control analytical methods: compounding slow-release pharmaceuticals. International Journal of Pharmaceutical Compounding 13(2): 144-145, 2009

Laser-ablated nanofunctional polymers for the formulation of slow-release powders for dry powder inhalers: physicochemical characterization and slow-release characteristics. Journal of Pharmacy and Pharmacology 59(11): 1473-1484, 2007

Comparative phase I randomized open-label pilot clinical trial of Gynophilus® (Lcr regenerans®) immediate release capsules versus slow release muco-adhesive tablets. European Journal of Clinical Microbiology & Infectious Diseases 37(10): 1869-1880, 2018

Production responses to slow release capsules containing magnesium. Occasional Publication, New Zealand Society of Animal Production 8(Dairy production from pasture): 400-401, 1982

Slow-release nutrient capsules for microorganism stimulation in oil remediation. Applied Biochemistry and Biotechnology 169(4): 1241-1249, 2013

Slow release silastic capsules for chronic administration of benzodiazepines. Society for Neuroscience Abstracts 19(1-3): 1456, 1993